Crescent Biopharma (CBIO) Current Deferred Revenue (2013 - 2026)
Crescent Biopharma (CBIO) posted quarterly Current Deferred Revenue of $3.1 million for Q2 2026, little changed quarter-over-quarter from $3.1 million in Q1 2026.
Crescent Biopharma (CBIO) Current Deferred Revenue (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Current Deferred Revenue for 8 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Deferred Revenue changed N/A year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was $4.2 million, changed N/A from the prior year.
- Current Deferred Revenue steadied at $3.1 million in Q2 2026 per CBIO's latest filing, from $3.1 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $4.2 million in Q4 2025 and bottomed at $3.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Crescent Biopharma | 1.10 Bn | 933.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.12 Mn |
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 4.16 Mn |
| Dec 31, 2018 | 98,771.00 |
| Sep 30, 2018 | 92,654.00 |
| Jun 30, 2018 | 86,637.00 |
| Mar 31, 2018 | 82,017.00 |
| Dec 31, 2017 | 78,028.00 |
| Sep 30, 2017 | 74,072.00 |
| Jun 30, 2017 | 70,598.00 |
| Mar 31, 2017 | 70,598.00 |
| Dec 31, 2016 | 68,551.00 |
| Sep 30, 2016 | 81,398.00 |
| Jun 30, 2016 | 81,398.00 |
| Jun 30, 2015 | 38,327.00 |
| Mar 31, 2015 | 67,965.00 |
| Dec 31, 2014 | 97,012.00 |
| Sep 30, 2014 | 115,050.00 |
| Jun 30, 2014 | 111,397.00 |
| Mar 31, 2014 | 107,686.00 |